Ziprasidone
Imran Qureshi, PharmD, BCPP
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Schizophrenia
Mixed or manic episodes in
bipolar I disorder
as monotherapy
Maintenance treatment of
bipolar I disorder
as an adjunct to lithium or valproate
Acute treatment of agitation in adults with schizophrenia (IM)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Management of
delirium
Adjunct to antidepressants in treating
major depressive disorder
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.